Review



tlqp-21  (Phoenix Pharmaceuticals)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Phoenix Pharmaceuticals tlqp-21
    (A) Annexin-V-PI staining to assess the apoptotic ratios of HUVECs with <t>TLQP-21</t> treated alone or under high glucose (HG) concentration (30 mmol/L) incubation for 72 h with or without TLQP-21(10–100 nM). (B) Cell viability of HUVECs under HG concentration (30 mmol/L) incubation for 72 h with or without TLQP-21(10–100 nM) protection.* p<.05,** p<.01 vs. saline treated group. (C) Cell viability of HUVECs with etoposide (0.2 mM) treatment for 72 h with or without TLQP-21(10–100 nM) protection. * p<.05, ** p<.01 vs. saline treated group. All data were collected from three independent experiments and are presented as the mean ±SD.
    Tlqp 21, supplied by Phoenix Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/tlqp-21/product/Phoenix Pharmaceuticals
    Average 90 stars, based on 1 article reviews
    tlqp-21 - by Bioz Stars, 2026-03
    90/100 stars

    Images

    1) Product Images from "TLQP-21 Protects Human Umbilical Vein Endothelial Cells against High-Glucose-Induced Apoptosis by Increasing G6PD Expression"

    Article Title: TLQP-21 Protects Human Umbilical Vein Endothelial Cells against High-Glucose-Induced Apoptosis by Increasing G6PD Expression

    Journal: PLoS ONE

    doi: 10.1371/journal.pone.0079760

    (A) Annexin-V-PI staining to assess the apoptotic ratios of HUVECs with TLQP-21 treated alone or under high glucose (HG) concentration (30 mmol/L) incubation for 72 h with or without TLQP-21(10–100 nM). (B) Cell viability of HUVECs under HG concentration (30 mmol/L) incubation for 72 h with or without TLQP-21(10–100 nM) protection.* p<.05,** p<.01 vs. saline treated group. (C) Cell viability of HUVECs with etoposide (0.2 mM) treatment for 72 h with or without TLQP-21(10–100 nM) protection. * p<.05, ** p<.01 vs. saline treated group. All data were collected from three independent experiments and are presented as the mean ±SD.
    Figure Legend Snippet: (A) Annexin-V-PI staining to assess the apoptotic ratios of HUVECs with TLQP-21 treated alone or under high glucose (HG) concentration (30 mmol/L) incubation for 72 h with or without TLQP-21(10–100 nM). (B) Cell viability of HUVECs under HG concentration (30 mmol/L) incubation for 72 h with or without TLQP-21(10–100 nM) protection.* p<.05,** p<.01 vs. saline treated group. (C) Cell viability of HUVECs with etoposide (0.2 mM) treatment for 72 h with or without TLQP-21(10–100 nM) protection. * p<.05, ** p<.01 vs. saline treated group. All data were collected from three independent experiments and are presented as the mean ±SD.

    Techniques Used: Staining, Concentration Assay, Incubation

    (A) The absorbance value of MTS assay with different treatments; the mannitol group was set as hyperosmosis control. *p<.05, **p<.01 vs. NC group; # p<.05, ## p<.01 vs. HG group. (B) Cell proliferation curve of HUVECs with different treatments. # p<.05, ## p<.01 NC&TLQP-21 group vs. HG group; *p<.05, **p<.01 HG+TLQP-21 group vs. HG group. (C) NADPH level of HUVECs with different treatments. **p<.01 vs. NC group; ## p<.01 vs. TLQP-21(10 nM) group. (D) Comparison of the NADPH level of HUVECs with and without TLQP-21(50 nM) treatment; the mannitol group was set as a hyperosmosis control. *p<.05, *p<.01 vs. TLQP-21 withdraw group. All data were collected from three independent experiments and are presented as the mean ±SD.
    Figure Legend Snippet: (A) The absorbance value of MTS assay with different treatments; the mannitol group was set as hyperosmosis control. *p<.05, **p<.01 vs. NC group; # p<.05, ## p<.01 vs. HG group. (B) Cell proliferation curve of HUVECs with different treatments. # p<.05, ## p<.01 NC&TLQP-21 group vs. HG group; *p<.05, **p<.01 HG+TLQP-21 group vs. HG group. (C) NADPH level of HUVECs with different treatments. **p<.01 vs. NC group; ## p<.01 vs. TLQP-21(10 nM) group. (D) Comparison of the NADPH level of HUVECs with and without TLQP-21(50 nM) treatment; the mannitol group was set as a hyperosmosis control. *p<.05, *p<.01 vs. TLQP-21 withdraw group. All data were collected from three independent experiments and are presented as the mean ±SD.

    Techniques Used: MTS Assay

    (A) G6PD activity of HUVECs with different treatments. **p<.01 vs. NC group. (B) mRNA level of G6PD with different treatments. **p<.01 vs. NC group (C) Western-blot analysis shows that G6PD expression decreased with G6PD siRNA. (D) G6PD activity decreases with G6PD siRNA. **p<.01 vs. scramble siRNA group. (E) G6PD siRNA attenuates the upregulation of NADPH when treated with TLQP-21. **p<.01 vs. scramble siRNA group. All data were collected from three independent experiments and are presented as the mean ±SD.
    Figure Legend Snippet: (A) G6PD activity of HUVECs with different treatments. **p<.01 vs. NC group. (B) mRNA level of G6PD with different treatments. **p<.01 vs. NC group (C) Western-blot analysis shows that G6PD expression decreased with G6PD siRNA. (D) G6PD activity decreases with G6PD siRNA. **p<.01 vs. scramble siRNA group. (E) G6PD siRNA attenuates the upregulation of NADPH when treated with TLQP-21. **p<.01 vs. scramble siRNA group. All data were collected from three independent experiments and are presented as the mean ±SD.

    Techniques Used: Activity Assay, Western Blot, Expressing



    Similar Products

    c3ar agonist tlqp 21  (MedChemExpress)
    93
    MedChemExpress c3ar agonist tlqp 21
    C3ar Agonist Tlqp 21, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/c3ar agonist tlqp 21/product/MedChemExpress
    Average 93 stars, based on 1 article reviews
    c3ar agonist tlqp 21 - by Bioz Stars, 2026-03
    93/100 stars
    		  Buy from Supplier
    tlqp-21, peptide sequence tlqppsalrrrhyhhalppsr  (Sangon Biotech)
    90
    Sangon Biotech tlqp-21, peptide sequence tlqppsalrrrhyhhalppsr
    Tlqp 21, Peptide Sequence Tlqppsalrrrhyhhalppsr, supplied by Sangon Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/tlqp-21, peptide sequence tlqppsalrrrhyhhalppsr/product/Sangon Biotech
    Average 90 stars, based on 1 article reviews
    tlqp-21, peptide sequence tlqppsalrrrhyhhalppsr - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    antibodies for tlqp-21  (Millipore)
    90
    Millipore antibodies for tlqp-21
    Antibodies For Tlqp 21, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibodies for tlqp-21/product/Millipore
    Average 90 stars, based on 1 article reviews
    antibodies for tlqp-21 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    tlqp-21  (Phoenix Pharmaceuticals)
    90
    Phoenix Pharmaceuticals tlqp-21
    (A) Annexin-V-PI staining to assess the apoptotic ratios of HUVECs with <t>TLQP-21</t> treated alone or under high glucose (HG) concentration (30 mmol/L) incubation for 72 h with or without TLQP-21(10–100 nM). (B) Cell viability of HUVECs under HG concentration (30 mmol/L) incubation for 72 h with or without TLQP-21(10–100 nM) protection.* p<.05,** p<.01 vs. saline treated group. (C) Cell viability of HUVECs with etoposide (0.2 mM) treatment for 72 h with or without TLQP-21(10–100 nM) protection. * p<.05, ** p<.01 vs. saline treated group. All data were collected from three independent experiments and are presented as the mean ±SD.
    Tlqp 21, supplied by Phoenix Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/tlqp-21/product/Phoenix Pharmaceuticals
    Average 90 stars, based on 1 article reviews
    tlqp-21 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    vgf-derived peptide tlqp-21  (Salton Inc)
    90
    Salton Inc vgf-derived peptide tlqp-21
    (A) Annexin-V-PI staining to assess the apoptotic ratios of HUVECs with <t>TLQP-21</t> treated alone or under high glucose (HG) concentration (30 mmol/L) incubation for 72 h with or without TLQP-21(10–100 nM). (B) Cell viability of HUVECs under HG concentration (30 mmol/L) incubation for 72 h with or without TLQP-21(10–100 nM) protection.* p<.05,** p<.01 vs. saline treated group. (C) Cell viability of HUVECs with etoposide (0.2 mM) treatment for 72 h with or without TLQP-21(10–100 nM) protection. * p<.05, ** p<.01 vs. saline treated group. All data were collected from three independent experiments and are presented as the mean ±SD.
    Vgf Derived Peptide Tlqp 21, supplied by Salton Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vgf-derived peptide tlqp-21/product/Salton Inc
    Average 90 stars, based on 1 article reviews
    vgf-derived peptide tlqp-21 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    tlqp 21 tfa  (MedChemExpress)
    93
    MedChemExpress tlqp 21 tfa
    (A) Annexin-V-PI staining to assess the apoptotic ratios of HUVECs with <t>TLQP-21</t> treated alone or under high glucose (HG) concentration (30 mmol/L) incubation for 72 h with or without TLQP-21(10–100 nM). (B) Cell viability of HUVECs under HG concentration (30 mmol/L) incubation for 72 h with or without TLQP-21(10–100 nM) protection.* p<.05,** p<.01 vs. saline treated group. (C) Cell viability of HUVECs with etoposide (0.2 mM) treatment for 72 h with or without TLQP-21(10–100 nM) protection. * p<.05, ** p<.01 vs. saline treated group. All data were collected from three independent experiments and are presented as the mean ±SD.
    Tlqp 21 Tfa, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/tlqp 21 tfa/product/MedChemExpress
    Average 93 stars, based on 1 article reviews
    tlqp 21 tfa - by Bioz Stars, 2026-03
    93/100 stars
    		  Buy from Supplier
    synthetic tlqp-21  (CPC Scientific)
    90
    CPC Scientific synthetic tlqp-21
    (A) Annexin-V-PI staining to assess the apoptotic ratios of HUVECs with <t>TLQP-21</t> treated alone or under high glucose (HG) concentration (30 mmol/L) incubation for 72 h with or without TLQP-21(10–100 nM). (B) Cell viability of HUVECs under HG concentration (30 mmol/L) incubation for 72 h with or without TLQP-21(10–100 nM) protection.* p<.05,** p<.01 vs. saline treated group. (C) Cell viability of HUVECs with etoposide (0.2 mM) treatment for 72 h with or without TLQP-21(10–100 nM) protection. * p<.05, ** p<.01 vs. saline treated group. All data were collected from three independent experiments and are presented as the mean ±SD.
    Synthetic Tlqp 21, supplied by CPC Scientific, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/synthetic tlqp-21/product/CPC Scientific
    Average 90 stars, based on 1 article reviews
    synthetic tlqp-21 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    murine purified tlqp-21  (Millipore)
    90
    Millipore murine purified tlqp-21
    (A) Annexin-V-PI staining to assess the apoptotic ratios of HUVECs with <t>TLQP-21</t> treated alone or under high glucose (HG) concentration (30 mmol/L) incubation for 72 h with or without TLQP-21(10–100 nM). (B) Cell viability of HUVECs under HG concentration (30 mmol/L) incubation for 72 h with or without TLQP-21(10–100 nM) protection.* p<.05,** p<.01 vs. saline treated group. (C) Cell viability of HUVECs with etoposide (0.2 mM) treatment for 72 h with or without TLQP-21(10–100 nM) protection. * p<.05, ** p<.01 vs. saline treated group. All data were collected from three independent experiments and are presented as the mean ±SD.
    Murine Purified Tlqp 21, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/murine purified tlqp-21/product/Millipore
    Average 90 stars, based on 1 article reviews
    murine purified tlqp-21 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    (A) Annexin-V-PI staining to assess the apoptotic ratios of HUVECs with TLQP-21 treated alone or under high glucose (HG) concentration (30 mmol/L) incubation for 72 h with or without TLQP-21(10–100 nM). (B) Cell viability of HUVECs under HG concentration (30 mmol/L) incubation for 72 h with or without TLQP-21(10–100 nM) protection.* p<.05,** p<.01 vs. saline treated group. (C) Cell viability of HUVECs with etoposide (0.2 mM) treatment for 72 h with or without TLQP-21(10–100 nM) protection. * p<.05, ** p<.01 vs. saline treated group. All data were collected from three independent experiments and are presented as the mean ±SD.

    Journal: PLoS ONE

    Article Title: TLQP-21 Protects Human Umbilical Vein Endothelial Cells against High-Glucose-Induced Apoptosis by Increasing G6PD Expression

    doi: 10.1371/journal.pone.0079760

    Figure Lengend Snippet: (A) Annexin-V-PI staining to assess the apoptotic ratios of HUVECs with TLQP-21 treated alone or under high glucose (HG) concentration (30 mmol/L) incubation for 72 h with or without TLQP-21(10–100 nM). (B) Cell viability of HUVECs under HG concentration (30 mmol/L) incubation for 72 h with or without TLQP-21(10–100 nM) protection.* p<.05,** p<.01 vs. saline treated group. (C) Cell viability of HUVECs with etoposide (0.2 mM) treatment for 72 h with or without TLQP-21(10–100 nM) protection. * p<.05, ** p<.01 vs. saline treated group. All data were collected from three independent experiments and are presented as the mean ±SD.

    Article Snippet: Human-derived TLQP-21 (TLGPPSALAAAHTHHALPPSA) was obtained from Phoenix pharmaceuticals (USA), and the scrambled peptide Scr-21 (LRPSHTRPAHQSFARPLHRPA) was synthesized by Apeptide (Shanghai, China)

    Techniques: Staining, Concentration Assay, Incubation

    (A) The absorbance value of MTS assay with different treatments; the mannitol group was set as hyperosmosis control. *p<.05, **p<.01 vs. NC group; # p<.05, ## p<.01 vs. HG group. (B) Cell proliferation curve of HUVECs with different treatments. # p<.05, ## p<.01 NC&TLQP-21 group vs. HG group; *p<.05, **p<.01 HG+TLQP-21 group vs. HG group. (C) NADPH level of HUVECs with different treatments. **p<.01 vs. NC group; ## p<.01 vs. TLQP-21(10 nM) group. (D) Comparison of the NADPH level of HUVECs with and without TLQP-21(50 nM) treatment; the mannitol group was set as a hyperosmosis control. *p<.05, *p<.01 vs. TLQP-21 withdraw group. All data were collected from three independent experiments and are presented as the mean ±SD.

    Journal: PLoS ONE

    Article Title: TLQP-21 Protects Human Umbilical Vein Endothelial Cells against High-Glucose-Induced Apoptosis by Increasing G6PD Expression

    doi: 10.1371/journal.pone.0079760

    Figure Lengend Snippet: (A) The absorbance value of MTS assay with different treatments; the mannitol group was set as hyperosmosis control. *p<.05, **p<.01 vs. NC group; # p<.05, ## p<.01 vs. HG group. (B) Cell proliferation curve of HUVECs with different treatments. # p<.05, ## p<.01 NC&TLQP-21 group vs. HG group; *p<.05, **p<.01 HG+TLQP-21 group vs. HG group. (C) NADPH level of HUVECs with different treatments. **p<.01 vs. NC group; ## p<.01 vs. TLQP-21(10 nM) group. (D) Comparison of the NADPH level of HUVECs with and without TLQP-21(50 nM) treatment; the mannitol group was set as a hyperosmosis control. *p<.05, *p<.01 vs. TLQP-21 withdraw group. All data were collected from three independent experiments and are presented as the mean ±SD.

    Article Snippet: Human-derived TLQP-21 (TLGPPSALAAAHTHHALPPSA) was obtained from Phoenix pharmaceuticals (USA), and the scrambled peptide Scr-21 (LRPSHTRPAHQSFARPLHRPA) was synthesized by Apeptide (Shanghai, China)

    Techniques: MTS Assay

    (A) G6PD activity of HUVECs with different treatments. **p<.01 vs. NC group. (B) mRNA level of G6PD with different treatments. **p<.01 vs. NC group (C) Western-blot analysis shows that G6PD expression decreased with G6PD siRNA. (D) G6PD activity decreases with G6PD siRNA. **p<.01 vs. scramble siRNA group. (E) G6PD siRNA attenuates the upregulation of NADPH when treated with TLQP-21. **p<.01 vs. scramble siRNA group. All data were collected from three independent experiments and are presented as the mean ±SD.

    Journal: PLoS ONE

    Article Title: TLQP-21 Protects Human Umbilical Vein Endothelial Cells against High-Glucose-Induced Apoptosis by Increasing G6PD Expression

    doi: 10.1371/journal.pone.0079760

    Figure Lengend Snippet: (A) G6PD activity of HUVECs with different treatments. **p<.01 vs. NC group. (B) mRNA level of G6PD with different treatments. **p<.01 vs. NC group (C) Western-blot analysis shows that G6PD expression decreased with G6PD siRNA. (D) G6PD activity decreases with G6PD siRNA. **p<.01 vs. scramble siRNA group. (E) G6PD siRNA attenuates the upregulation of NADPH when treated with TLQP-21. **p<.01 vs. scramble siRNA group. All data were collected from three independent experiments and are presented as the mean ±SD.

    Article Snippet: Human-derived TLQP-21 (TLGPPSALAAAHTHHALPPSA) was obtained from Phoenix pharmaceuticals (USA), and the scrambled peptide Scr-21 (LRPSHTRPAHQSFARPLHRPA) was synthesized by Apeptide (Shanghai, China)

    Techniques: Activity Assay, Western Blot, Expressing